-+ 0.00%
-+ 0.00%
-+ 0.00%

*NervGen Pharma: Restatement Expected to Reduce Previously Reported Stock-Based Compensation Expense >NGEN

Dow Jones·09/25/2026 20:33:00

Please log in to view news